Nadia Madrid-Elena

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

Carolina Gutiérrez, Sergio Serrano‐Villar, Nadia Madrid-Elena et al. · AIDS · 2016 · 201 citations

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1

María Rosa López‐Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena et al. · Scientific Reports · 2017 · 50 citations · Full text

Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4⁺T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Nadia Madrid-Elena, Laura García‐Bermejo, Sergio Serrano‐Villar et al. · Journal of Virology · 2018 · 46 citations · Full text

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C)

Beatriz Hernández‐Novoa, Antonio Moreno, Maria Jesús Pérez‐Elías et al. · Journal of Antimicrobial Chemotherapy · 2013 · 23 citations · Full text

Effect of the Use of Galectin-9 and Blockade of the TIM-3 Receptor in the Latent Cellular Reservoir of HIV-1

Marta Sanz, Nadia Madrid-Elena, Sergio Serrano‐Villar et al. · Journal of Virology · 2020 · 19 citations · Full text